综述

白细胞介素21与单克隆抗体联用在肿瘤治疗中的效果研究

  • 岳坤 杨海瑞 徐帆洪
展开
  • 200051 上海生物制品研究所有限责任公司第一研究室

网络出版日期: 2025-08-16

Study on the effect of IL-21 combined with monoclonal antibody in tumor therapy

Expand
  • No. 1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai 200051,China

Online published: 2025-08-16

摘要

 白细胞介素21(interleukin-21,IL-21)是由4个α螺旋束寡聚而成的Ⅰ型细胞因子,与IL-2、IL-4和IL-15高度同源,具有多重免疫调节作用。相关研究表明,IL-21与某些肿瘤密切相关。作为一种极具潜力的免疫调节剂,IL-21在肿瘤治疗中具有广阔的应用前景。IL-21与部分单克隆抗体联用能在肿瘤治疗中发挥协同效应。此文就IL-21与部分单克隆抗体联用治疗肿瘤的效果进行综述。

本文引用格式

岳坤 杨海瑞 徐帆洪 . 白细胞介素21与单克隆抗体联用在肿瘤治疗中的效果研究[J]. 国际生物制品学杂志, 2016 , 39(3) : 134 -137 . DOI: 10.3760/cma.j.issn.1673-4211.2016.03.006

Abstract

 Interleukin-21 (IL-21) is a typeⅠcytokine made of 4 α helical bundles. IL-21 is highly homologous with IL-2, IL-4 and IL-15, and plays various roles in immunoregulation. Related researches show that IL-2 is closely linked with some tumors. As a potential immunomodulator, IL-21 has promising application prospects in tumor therapy. IL-21 combined with monoclonal antibody has a synergistic effect in tumor therapy. In this paper, the effect of IL-21 combined with monoclonal antibody in tumor therapy is reviewed.
文章导航

/